New Search

Your search found 27 VIDEOS, WORKSHOPS, and WEBINARS.

Article (Peer-Reviewed)

1. Causes of Death and Expected Years of Life Lost Among Treated Opioid-Dependent Individuals in the United States and Taiwan. doc type
  Chang, Kun-Chia ; Wang, Jung-Der ; Saxon, Andrew J. ; Matthews, Abigail G. ; Woody, George E. ; Hser, Yih-Ing
 International Journal of Drug Policy 2017;45:1-6. [doi: 10.1016/j.drugpo.2016.12.003].
 
2. Distinctive Trajectories of Opioid Use Over an Extended Follow-Up of Patients in a Multisite Trial on Buprenorphine + Naloxone and Methadone. doc type
  Hser, Yih-Ing ; Huang, David ; Saxon, Andrew J. ; Woody, George ; Moskowitz, Andrew L. ; Matthews, Abigail G. ; Ling, Walter
 Journal of Addiction Medicine 2017;11(1):63-69. [doi: 10.1097/ADM.0000000000000274].
 
3. Chronic Pain Among Patients with Opioid Use Disorder: Results from Electronic Health Records Data. doc type
  Hser, Yih-Ing ; Mooney, Larissa J. ; Saxon, Andrew J. ; Miotto, Karen ; Bell, Douglas S. ; Huang, David
 Journal of Substance Abuse Treatment 2017;77:2630. [doi: 10.1016/j.jsat.2017.03.006].
 
4. High Mortality Among Patients with Opioid Use Disorder in a Large Healthcare System. doc type
  Hser, Yih-Ing ; Mooney, Larissa J. ; Saxon, Andrew J. ; Miotto, Karen ; Bell, Douglas S. ; Zhu, Yuhui ; Liang, Di ; Huang, David
 Journal of Addiction Medicine 2017 (in press). [doi: 10.1097/ADM.0000000000000312].
 
5. A Polymorphism in the OPRM1 3'-Untranslated Region is Associated with Methadone Efficacy in Treatment Opioid Dependence. doc type
  Crist, Richard C. ; Doyle, Glenn A. ; Nelson, Elliot C. ; Degenhardt, Louisa ; Martin, Nicholas G. ; Montgomery, Grant W. ; Saxon, Andrew J. ; Ling, Walter ; Berrettini, Wade H.
 Pharmacogenomics Journal 2016 (in press). [doi: 10.1038/tpj.2016.89].
 
6. Long-Term Outcomes After Randomization to Buprenorphine/Naloxone Versus Methadone in a Multi-Site Trial. doc type
  Hser, Yih-Ing ; Evans, Elizabeth ; Huang, David ; Weiss, Roger D. ; Saxon, Andrew J. ; Carroll, Kathleen M. ; Woody, George E. ; Liu, David S. ; Wakim, Paul G. ; Matthews, Abigail G. ; Hatch-Maillette, Mary A. ; Jelstrom, Eve ; Wiest, Katharina L. ; McLaughlin, Paul ; Ling, Walter
 Addiction 2016;111(4):695-705. [doi: 10.1111/add.13238].
 
7. Buprenorphine-Naloxone plus Naltrexone for the Treatment of Cocaine Dependence: The Cocaine Use Reduction with Buprenorphine (CURB) Study. doc type
  Ling, Walter ; Hillhouse, Maureen P. ; Saxon, Andrew J. ; Mooney, Larissa J. ; Thomas, Christie ; Ang, Alfonso ; Matthews, Abigail G. ; Hasson, Albert L. ; Annon, Jeffrey J. ; Sparenborg, Steven ; Liu, David S. ; McCormack, Jennifer ; Church, Sarah ; Swafford, William ; Drexler, Karen ; Schuman, Carolyn ; Ross, Stephen ; Wiest, Katharina L. ; Korthuis, P. Todd ; Lawson, William ; Brigham, Gregory S. ; Knox, Patricia C. ; Dawes, Michael ; Rotrosen, John
 Addiction 2016;111(8):1416-1427. [doi: 10.1111/add.13375].
 
8. Treatment Outcomes in Opioid Dependent Patients with Different Buprenorphine/Naloxone Induction Dosing Patterns and Trajectories. doc type
  Jacobs, Petra ; Ang, Alfonso ; Hillhouse, Maureen P. ; Saxon, Andrew J. ; Nielsen, Suzanne ; Wakim, Paul G. ; Mai, Barbara E. ; Mooney, Larissa J. ; Potter, Jennifer Sharpe ; Blaine, Jack D.
 American Journal on Addictions 2015;24:667-675. [doi: 10.1111/ajad.12288].
 
9. Risk Factors Associated with HCV Among Opioid-Dependent Patients in a Multisite Study. doc type
  Schulte, Marya T. ; Hser, Yih-Ing ; Saxon, Andrew J. ; Evans, Elizabeth ; Li, Libo ; Huang, David ; Hillhouse, Maureen P. ; Thomas, Christie ; Ling, Walter
 Journal of Community Health 2015;40(5):940-947. [doi: 10.1007/s10900-015-0016-2].
 
10. Genetic Variation in OPRD1 and the Response to Treatment for Opioid Dependence with Buprenorphine in European American Females. doc type
  Clarke, Toni-Kim ; Crist, Richard C. ; Ang, Alfonso ; Ambrose-Lanci, Lisa ; Lohoff, Falk W. ; Saxon, Andrew J. ; Ling, Walter ; Hillhouse, Maureen P. ; Bruce, R. Douglas ; Woody, George E. ; Berrettini, Wade H.
 Pharmacogenomics Journal 2014;14:303-308. [doi: 10.1038/tpj.2013.30].
 
11. Treatment Retention Among Patients Randomized to Buprenorphine/Naloxone Compared to Methadone in a Multi-Site Trial. doc type
  Hser, Yih-Ing ; Saxon, Andrew J. ; Huang, David ; Hasson, Albert ; Thomas, Christie ; Hillhouse, Maureen ; Jacobs, Petra ; Teruya, Cheryl ; McLaughlin, Paul ; Wiest, Katharina ; Cohen, Allan J. ; Ling, Walter
 Addiction 2014;109(1):79-87. [doi: 10.1111/add.12333].
 
12. HIV Risk Reduction with Buprenorphine-Naloxone or Methadone: Findings from A Randomized Trial. doc type
  Woody, George E. ; Bruce, R. Douglas ; Korthuis, P. Todd ; Chhatre, Sumedha ; Hillhouse, Maureen P. ; Jacobs, Petra ; Sorensen, James L. ; Saxon, Andrew J. ; Metzger, David S. ; Ling, Walter
 Journal of Acquired Immune Deficiency Syndromes 2014;66(3):288-293. [doi: 10.1097/QAI.0000000000000165].
 
13. An Intronic Variant in OPRD1 Predicts Treatment Outcome for Opioid Dependence in African-Americans. doc type
  Crist, Richard C. ; Clarke, Toni-Kim ; Ang, Alfonso ; Ambrose-Lanci, Lisa ; Lohoff, Falk W. ; Saxon, Andrew J. ; Ling, Walter ; Hillhouse, Maureen P. ; Bruce, R. Douglas ; Woody, George E. ; Berrettini, Wade
 Neuropsychopharmacology 2013;38:2003-2010. [doi: 10.1038/npp.2013.99].
 
14. Cocaine Use Reduction with Buprenorphine (CURB): Rationale, Design, and Methodology. doc type
  Mooney, Larissa J. ; Nielsen, Suzanne ; Saxon, Andrew J. ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Stablein, Don ; McCormack, Jennifer ; Lindblad, Robert ; Ling, Walter
 Contemporary Clinical Trials 2013;34(2):196-204. [doi: 10.1016/j.cct.2012.11.002].
 
15. Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings from Starting Treatment with Agonist Replacement Therapies (START). doc type
  Potter, Jennifer Sharpe ; Marino, Elise N. ; Hillhouse, Maureen P. ; Nielsen, Suzanne ; Wiest, Katharina ; Canamar, Catherine P. ; Martin, Judith A. ; Ang, Alfonso ; Baker, Rachel ; Saxon, Andrew J. ; Ling, Walter
 Journal of Studies on Alcohol and Drugs 2013;74(4):605-613..
 
16. Buprenorphine/Naloxone and Methadone Effects on Laboratory Indices of Liver Health: A Randomized Trial. doc type doc type
  Saxon, Andrew J. ; Ling, Walter ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Ang, Alfonso ; Doraimani, Geetha ; Tasissa, Gudaye ; Lokhnygina, Yuliya ; Leimberger, Jeffrey D. ; Bruce, R. Douglas ; McCarthy, John ; Wiest, Katharina ; McLaughlin, Paul ; Bilangi, Richard ; Cohen, Allan J. ; Woody, George E. ; Jacobs, Petra
 Drug and Alcohol Dependence 2013;128(1-2):71-76. [doi: 10.1016/j.drugalcdep.2012.08.002].
 
17. From Research to the Real World: Buprenorphine in the Decade of the Clinical Trials Network. doc type
  Ling, Walter ; Jacobs, Petra ; Hillhouse, Maureen P. ; Hasson, Albert L. ; Thomas, Christie ; Freese, Thomas E. ; Sparenborg, Steven ; McCarty, Dennis ; Weiss, Roger D. ; Saxon, Andrew J. ; Cohen, Allan J. ; Straus, Michele M. ; Brigham, Gregory S. ; Liu, David S. ; McLaughlin, Paul ; Tai, Betty
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S53-S60. [doi: 10.1016/j.jsat.2010.01.009].
 
18. Study Results from the Clinical Trials Network's First 10 Years: Where Do They Lead? doc type
  Wells, Elizabeth A. ; Saxon, Andrew J. ; Calsyn, Donald A. ; Jackson, T. Ronald ; Donovan, Dennis M.
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S14-S30. [doi: 10.1016/j.jsat.2009.12.009].
 
19. Buprenorphine Tapering Schedule and Illicit Opioid Use. doc type doc type
  Ling, Walter ; Hillhouse, Maureen P. ; Domier, Catherine P. ; Doraimani, Geetha ; Hunter, Jeremy ; Thomas, Christie ; Jenkins, Jessica ; Hasson, Albert L. ; Annon, Jeffrey J. ; Saxon, Andrew J. ; Selzer, Jeffrey A. ; Boverman, Joshua ; Bilangi, Richard
 Addiction 2009;104(2):256-265 [doi: 10.1111/j.1360-0443.2008.02455.x].
 
20. Challenges in the Adoption of New Pharmacotherapeutics for Addiction to Alcohol and Other Drugs. doc type
  Saxon, Andrew J. ; McCarty, Dennis
 Pharmacology & Therapeutics 2005;108:119-128. [doi: 10.1016/j.pharmthera.2005.06.014].
 

Poster

21. Induction Onto Extended-Release Naltrexone in 302 Cocaine-Dependent Opioid Users. doc type
  Lindblad, Robert ; McCormack, Jennifer ; Saxon, Andrew J. ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Mooney, Larissa ; VanVeldhuisen, Paul C. ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Diego, CA, June 15-20, 2013.
 

Presentation

22. Protocol: NIDA-CTN-0027: Starting Treatment with Agonist Replacement Therapies (START). doc type
  Ling, Walter ; Saxon, Andrew J.
 Presented at the American Public Health Association (APHA) annual meeting, Washington, DC, Oct. 28 - Nov. 2, 2011.
 

Video

23. Effective Approaches to Addressing Patients with Substance Use Disorders in the Emergency Department: A Knowledge Exchange. [Blending Initiative Workshop] doc type doc type
  Ranney, Megan L. ; Saxon, Andrew J. ; Todd, Knox H. ; Babu, Kavita M. ; Boyer, Edward W. ; Ringwalt, Chris L. ; Neven, Darin E. ; Nelson, Lewis S. ; Graykoski, John J. ; D'Onofrio, Gail ; Zatzick, Douglas F. ; Cunningham, Rebecca M. ; Dunn, Christopher W. ; Bernstein, Edward ; Broderick, Kerryann B. ; Howard, Patricia K.
 Sponsored by the NIDA/SAMHSA Blending Initiative, American College of Emergency Physicians, and the Centers for Control and Prevention, Seattle, WA, October 13, 2013.
 
24. Cocaine Use Reduction with Buprenorphine (CURB: CTN-0048): Protocol Overview. doc type
  Mooney, Larissa ; Saxon, Andrew J. ; Ling, Walter
 Webinar sponsored by the NIDA Clinical Coordinating Center, May 11, 2011.
 

Webinar

25. CTN Webinar: Developing Medication Assisted Treatment (MAT) Protocols. doc type
  Saxon, Andrew J.
 Produced by the National Drug Abuse Treatment Clinical Trials Network's Clinical Coordinating Center, July 17, 2013.
 

Workshop

26. Effective Approaches to Addressing Patients with Substance Use Disorders in the Emergency Department: A Knowledge Exchange. [Blending Initiative Workshop] doc type doc type
  Ranney, Megan L. ; Saxon, Andrew J. ; Todd, Knox H. ; Babu, Kavita M. ; Boyer, Edward W. ; Ringwalt, Chris L. ; Neven, Darin E. ; Nelson, Lewis S. ; Graykoski, John J. ; D'Onofrio, Gail ; Zatzick, Douglas F. ; Cunningham, Rebecca M. ; Dunn, Christopher W. ; Bernstein, Edward ; Broderick, Kerryann B. ; Howard, Patricia K.
 Sponsored by the NIDA/SAMHSA Blending Initiative, American College of Emergency Physicians, and the Centers for Control and Prevention, Seattle, WA, October 13, 2013.
 
27. From START to Finish: National and International Perspectives on Disseminating Research to Practice for the Treatment of Opioid Dependence. doc type
  Saxon, Andrew J. ; Woody, George E. ; Jacobs, Petra ; Crist, Richard C. ; Nurhidayat, Adhi Wibowo ; Hickman, Mathew ; Strang, John
 Blending Initiative Workshop sponsored by the National Institute on Drug Abuse (NIDA), the National Drug Abuse Treatment Clinical Trials Network (CTN), and the NIDA/SAMHSA Blending Initiative in collaboration with the American Association for the Treatment of Opioid Dependence (AATOD), Philadelphia, PA, November 10, 2013.